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Blood tests showed an increase of the inflammation biological mark- 
ers with a normal leukocyte count. Lyme serology was positive by 
ELISA and Western blot. DNA amplification by P C R  specific for B. 
burgdofeferi sensu lato was positive in a synovial fluid sample. The 
patient was then treated for 2 weeks with intravenous ceftriaxone (2 
g/day) and completely cured. No recurrence was observed after 8 
months of follow-up. To identify the B. burgdoferi species involved 
in t h s  arthritis, a species-specific dot-blot hybridization assay was 
performed on the PCR product with oligonucleotide probes specific 
for the different €3. burgdoferi species. A signal was observed with the 
B. p r i n i i  probe, whereas no signal was detected with probes specific 
for B. burgdoferi sensu stricto, B. afielii and 8. valaisiana. 
Conclusions: B. garinii can be implicated in European Lyme 
arthritis. 
lp6461 Clinical outcome of patients after tick bite 
I. Nahimana', €? Francioli', L. Gem2, 0. Pites, G. Praz". 'CHUI:  
Lausanne, zUniversit4 de NeuchhBtel, 'lnst. Central des Hdpitaux 
Valairans, Sion, Switzerland 
Objectives: To assess the immediate and long-term outcome of 
patients who presented with tick bite and were followed at 0, 2, 12 
and 24 months without antibiotic treatment. 
Methods: Since 1993, physicians of the western part of 
Switzerland have been asked to report on all patients consulting for 
a tick bite. The protocol included a standardized questionnaire, two 
blood samples collected 2 months apart and mailing of the tick if 
available. Serology was performed with a commercial test (Lyme 
IgG+M, Vidas, Biomkieux) and all positive tests were assessed using 
a Western blot assay detecting both IgG and IgM. Thereafter a 
subgroup of patients was followed over a 2-year period, to compare 
the clinical outcome of a group of asymptomatic patients with sero- 
conversion with that of patients with two negative serology results 
and patients with two positive serology results for Lyme borreliosis. 
The protocol included questionnaires and two blood samples 1 year 
apart. 
Results: A total of 751 patients were referred for a tick bite and 
two serology tests performed 2 months apart. Among them, 41 
patients were followed, with 17 in the negative serology group, 9 in 
the seroconversion groupand 15 in the positive serology group. One 
patient who seroconverted developed an erythema migrans. The 
proportions of patients with neurologic manifestations (6/17; 5/9; 
7/15) and rheumatogic manifestations (5/17; 4/9; 6/15) were simi- 
lar in the three groups. In the positive serology group, 2 patients with 
neurologic manifestations were hospitahzed and operated on for 
vertebral disk hernia. In the negative serology group, one patient was 
suspected to have neuroborreliosis, No patient had a typical mani- 
festation of Lyme disease. 
Conclusions: Late clinical manifestations of Lyme borreliosis 
were rarely observed after a proven tick bite. The clinic represents a 
large part in talung decision of Lyme disease hagnosis, even the serol- 
ogy is negative. There was no detectable clinical difference at 2 years 
between patients with seroconversion and those of the other two 
groups. 
(p6471 Clinical aspects of tick-borne encephalitis (TBE) 
I. Ruskuviene. Department qf In+ctiouj Diseases, Huspital of Siauliai, 
Siauliai, Lithuania 
The data from 367 patients treated for TBE in Siauliai hospital over 
a period of 5 years (1 993-97) are presented. Most of the patients were 
treated in 1997 (112, i.e. 31%). There were no fatal cases. There were 
more male (56%) than female patients. 187 patients (51%) were tiom 
Siauliai city, and the others were from Siauliai district. Most of the 
patients were 20-60 years old (70%). 41 cases were children. The 
disease is seasonally prevalent-the peak was reached in August (141 
patients) and September (83 patients). Tick bite was confirmed in 
74% of the patients. The incubation period varied from 1 to 45 days. 
Cases of mehum severity of TBE dominated (64% of patients). The 
general infectious form of TBE was defined for 11%. meningic for 
47%, meningoencephalitic for 38% and meningoencephalomyelitic 
for 4% of patients. Paresis of spinal nerves developed in 9 cases. 
Among the clinical manifestations of the disease, headache and/or 
vertigo (97%). nausea and/or vomiting (76%). tremor (48%) and 
hsturbances of consciousness (39%) were frequently seen. The clin- 
ical hagnosis of TBE was based on a positive serologic hemaggluti- 
nation inhibition test for 91% of the patients (1993-96) and on a 
positive enzyme immunoassay, when specific IgM antibodies were 
identified, for 88% of the patients (1997). The possibility of the 
transplacental transmission of TBE is discussed. 
Helicobacter pylori 
lp6481 Clarithromycin susceptibility of H. pylori 
strains in Estonia 
K. LGivukene'.', H. Kolk3, H.-I. Maaroos3, M. Mikelsaa?. 'Lab. 
Microbiolo,, United Laboratories, Clinicurn .f the University of Tartu, 
*Department of Microbiology, -'Department of Family Medicine, University 
of Tartu, Tartu, Estonia 
Clarithromycin is a macrolide used in multidrug regimens (omepra- 
zole+ amoxycillin+clarithromycin) for treatment of H. pylori- 
derived infections. The larithromycin resistance rate in Europe varies 
from 0% to 15% and seems to be associated with the extensive use of 
the antibiotic. Clarithromycin was ordinarily registered in 1997 in 
Estonia and the population has not been treated with clarithromycin 
before. However, eradication by the macrolide clarithromycin may 
fail due to acquired resistance of H .  pylori. 
Objectives: To test Estonian H .  pylori strains for clarithromycin 
susceptibility 
Methods: We examined 30 strains of H .  pylori isolated from 
gastric mucosa of adult patients with gastritis and peptic ulcer. H. 
pylori was isolated on Columbia Agar Base supplemented with 7% 
horse blood and 1% Isovitalex. Plates were incubated for 3-4 days at 
37OC under micro-aerophilic conditions (CampyGen). Each plate 
was swabbed with Brucella broth to produce a heavy suspension 
(McFarland 3). Clarithromycin susceptibility testing was done using 
Etest (AB Biodisk). The plates were incubated at 37OC under micro- 
aerophilic conditions for 3-4 days before examination. H .  pylori 
strains with MIC 2.0 mg/L were regarded as clarithromycin sensi- 
tive. 
Results: All 30 tested strains were sensitive to clarithromycin. 
(MIC 0.0016-0.75 mg/L). 
Conclusions: Clarithromycin resistance has not yet been detected 
among H .  pylori strains in the Estonian population. Thus, clar- 
ithromycin seems to be an excellent part of the triple therapy for 
eradication of H. pylori. 
A b s t r a c t s  
lp6491 Survival of Helibobacter py/ori in HUT medium 
K. Vogt. Hirmholdt Uniiwsiry/Charite Hospital, Berlin, Germany 
Objectives: To investigate the survival of Hclicobucfar pylori (Hp) in 
Hp urease test (HUT) medium. Due to rising resistance of Hp. 
microbiological examination and testing of antimicrobial substances 
is becoming ever more important. Since cultivation of Hp requires 
at least two extra biopsies, most gastroenterologists just perform the 
H U T  as a quick and convenient, but indirect, method to identify Hp. 
We investigated whether Hp can survive 2-4 h within H U T  medium 
and be cultivated on agar thereafter. Thus, physicians would need to 
select only positive HUTS for processing in the laboratory 
Methods: 48 freshly isolated Hp strains were suspended in 
Brucella broth a t  lO"-lO' CFU/niL and 10-fold dilutions were made. 
Test disks were soaked with 1 10 pL of the Hp suspensions. One disk 
was put directly on Columbia agar, and the second and third disks 
into H U T  medium for 2 and 4 h, respectively. All 48 isolates were 
investigated at 22"C, and 15 strains additionally a t  37°C. 
Results: lO'-lO' CFU/inL led to 92-94% recovery after 2 h and 
73-83% recovery after 4 h. 106-108 CFU/niL yielded 73% after 2 h, 
and 38% after 4 h. At 37OC, the results were 73-93% after 2 h, and 
40-80% after 4 h. 
Conclusions: Hp concentrations of 1 05-107 CFU/niL in gastric 
biopsies survive up to 4 h in H U T  niedium. Very high and low inoc- 
ula yield lower rates. Thus, H U T  helps to save Hp in gastric biop- 
sies for further microbiological cultivation. 
Ip6501 The seroprevalence of CagA and VacA 
antibodies to H. py/ori in duodenal ulcer 
patients 
G. Gosciniak', E. Poniewierka', A. Przondo-Modarska'. 
Dcpnrtnzmts OJ 'Microbiology und z G a s t r ~ ~ c ~ ~ t c ~ ~ ~ / ~ ~ ~ y ,  University .f 
hledicinc, Wrorlairl, Poland 
Objectives: To investigate serum antibody response to CagA and 
VacA in H. pylori-infected patients with duodenal ulcer. 
Methods: Follow-up sera and gastric ~nucosa samples were taken 
(mean age 48) from patients with duodenal ulcer over 24 months. H .  
pylori was looked for histologicdly on  gastric biopsy specimens. The 
first histologic examination detected H. pyluri infection in each of the 
patients. lgC antibodies to H. pylori were detected by in-house 
ELISA, using three antigens: the sonicate from the reference strain 
N C T C  1 1637 ,~  purified recombinant fragment I (orv 220, Ova Vax, 
Cambridge USA), or the H. pylori culture supernatant from the tox+ 
strain CCUG 17974. 
Results: The first examination, prior to treatment, detected IgG 
antibodies in all patients. Antibodies to CagA and VacA were 
detected in the serum samples from untreated patients in the follwing 
proportions: CagA in 14 out of 20 (70%) and VacA in 12 out of 20 
(60%) subjects. Two subjects (who were serologically negative to 
VacA in the first examination) showed an anti-VacA antibody 
response and the presence of H. pylori after 24 months of follow-up. 
I n  10 subjects, who were H. pylori negative after 24 months offollow- 
up, there was a noticeable decrease in the anti-VacA and a slight 
decrease in the anti-CagA antibody levels. 
Conclusions: The absence of anti-VacA antibodm in the first 
examination and their presence during follow-up suggest reinfection 
by another H. p y h i  (tox') strain. The noticeable decrease in the anti- 
VacA antibody level during follow-up indicates that monitoring of 
the anti-Vac antibody behavior may be useful in establishing whether 
the therapy has been successful or not. 
Ip651) Relationship between reinfection and IgG 
antibody titers to H. pyfori: results of a 48- 
month follow-up 
G. Gosciniak', A. Przondo-Mordarska', E. Poniewierka'. 
Deparrmenrs .f 'Microbiulq~y and 'Gastnitn~~ruk~~y,, I!ttrvwz.iry sf 
Mcdicirte, Wrorlaw, Polatid 
Objectives: To observe the changes of antibody titers to H .  
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pyluri 
during successful eradication therapy and reinfections in patients with 
chronic gastritis and duodenal ulcer. 
Methods: Sera and gastric niucosa sainples were taken from 82 
patients (mean age 46) with duodenal ulcer (30) and chronic p t r i -  
tis (52) in a 48-month follow-up within the periodl990-96. 
Specimens were collected before treatnient and aftcr 3. 6, 12, 24, 36 
and 48 months. H. pylori infection was cvaluated by culture and rapid 
urease test. Serum \ampler were analyzed by an iti-house ELISA for 
IgG antibodies to a sonicated H. pylori antigen. The patients rcccived 
dual therapy: colloidal bismuth or ranitidine in  coinbin.ition wlth 
metronidazole or erythromycin in 1990-94, and PI'I with amoxy- 
cillin in 1995-06. 
Results: While at their first exaniination all patients were H.  pylori 
positive and seropositive, 3 months aftcr the end of the treatment, 
eradication of H. pylori was found in all of them, but IgG mtibody 
titer decreased slightly in 45% ofpatients. A decreace i n  IgG antibody 
titer by 40% was observed after 6 months following the first exain- 
nation. Within the 48-month follow-up, anti-H. pykwi IgG antibody 
titer decreased significantly from OL) 2.0 to 0.5 in patients with 
successful eradication. In the first year after treatment, 40'% ofpatients 
were reinfected, and in the third and fourth years reinfection was 
detected in 8.5% of patients. Total reinfection detected i n  the 4X- 
month period was 59.8% 
Conclusions: Each reinfection was concoillitant with a visible 
increase of antibody titer. Four years after eradication of N. pylori, 
30% of patients were still seropositive. 
lp6521 Recrudescence of H. py/ori after treatment 
with omeprazole, metronidazole and 
amoxycillin causes no genetic changes 
1. Adanisson, C. Edlund, R. Seensalu, L. Engstrand. I(orolin,k 
liistitutct, Huddinge University Huspital, S~ockhulrti, Strvdcri 
Objectives: (1) To fingerprint H. pylori strains isolated from p'itients 
where H. pyfori had ieoccurred after antiiiiicrobial treatment, in order 
to determine if the patients were reinfected with a new strain or if 
the patients were still infected with the original straiii (recrudes- 
cence). 
Materials and methods: Helicobaercr pylori was isolated in four 
patients, 1 month after treatment in a study of 31 patients. All four 
patients were treated with omeprazole 20 mg b.i.d., metronidazole 
400 mg b.i.d., and amoxycillin 1000 nig b.i.d., for 1 wcck. Fifty 
wains from antruin and fifty from corpus, both before and after treat- 
nient, were fingerprinted with AP-PCK. Representative strain\ with 
different AP-PCR patterns were used for RFLI' (Hlinl, DI?~JII, and 
Ald ) after amplification of the H .  p)dori flagcllin gcne.finA. Strains 
were alto tested for the presence of the cqA and I M ~ A  genes with 
PCR. 
Results: When subjected to RFLP, all colonies from the same 
patient gave the same genoniic fingerprint by the obtained IIFLI' 
pattern in each of the performed digestions, independent of the All- 
PCR status. Large differences were seen between the patients. The 
caXA gene was absent in one patient and present in two, while one 
patient had a mixed iiifection with both cqA-positive and ra~qA-nega- 
tive strains The majority of ?trains had the rarA allelc \ lm2 
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--roverall 
Overall I 
OMC 142/48(87.5%) 
OAC 1 21/27 (7_7,8%) 
Conclusions: Patients treated with a triple regimen consisting of 
omeprazole/metronidazole/amoxycillin are recolonized with the 
same strain that they were infected with before treatment, and no  
genetic changes seem to have occurred. There are no differences in 
the presence of virulence factors before and after treatment. 
~- 
NO Res MTR R CLA R 
3 3 / 3 5  (94%) 27 /32  (84%) 9/16 (56%) 
22/23 (96%) 18/21 (86%) 6 / 9  (66%) 
I 1  / 12 (92%) 9 / 11 (82%) 3 / 7 (43%) 
)p653) H. p y h i  resistance to metronidazole and 
clarithromycin: effect on the outcome of 
eradication therapy 
M. V Zanetti’, 0. Pieramico’, R. Vendramin’. ’Laboratory of 
Microbiology, ZDivision o f  Internal Medicine, Hospital ‘E Tnppeiner’, 
Merano, Italy 
Primary or acquired resistance (R) to metronidazole (MTR) and 
clarithromycin (CLA), frequently used in triple therapy regimens, is 
an emerging problem with an impact on the outcome of therapy for 
eradication of H.  pylori. 
Objectives: To investigate HP eradication with different omepra- 
zole-based triple therapies in relation to M T R  R and CLA R. 
Patients and methods: A total of 75 symptomatic HP-positive 
patients (46 M, 29 F, range 18-75 years, mean 44.5 years) were 
included. During endoscopy, five biopsies were taken from antrum 
and corpus for histology, rapid urease test and culture. Culture was 
performed using blood-free agar plates. HP-positive cultures were 
then subcultured and antimicrobial susceptibility to M T R  and CLA 
was tested by the ‘disk diffusion’ method. Patients were assigned to 
one of the two following treatments based on omeprazole (OAM or 
OAC). Erahcation was then evaluated with endoscopy and biopsies 
at 6-10 weeks after therapy. 
Results: Resistant strains were detected in 40 cultures out of 75 
(53%). Overall, H P  was successfully cured in 63 out of 75 patients 
(84%). Independently of therapy regimen, eradication was 94% 
against susceptible strains (33/35 patiens) but dropped to 75% (30/40 
patients) against resistant strains. Eradication according to antimicro- 
bial R and type of therapy was: 
Conclusions: Antibiotic resistance has a clear impact 011 the 
outcome of triple therapy for HP eradication, causing a drop of about 
20% in success rate. CLA resistance seems to have a greater impact 
(almost 40% reduction) on the outcome of therapy than M T R  resis- 
tance (10% reduction). OMC and OAC are equally effective against 
HP-susceptible strains and against MTR-resistant strains. O M C  
achieved better results than OAC against CLA-resistant strains. 
[p6541 H. pylori resistance to metronidazole and 
clarithromycin: is it related to the presence of 
CagA? 
M.V. Zanetti’, 0. Pieramico’, A. Mutschlechner’. ’Laboratory o j  
Microbiology and Clinical Cliernistry, ’Division of Internal Medicine, 
Hospital ‘E Tnppeiner’, Merano, Italy 
Metronidazole (MTR) and clarithromycin (CLA) are frequently used 
in combination with PPI in the treatment of H. pylori (HP) infec- 
tion. Antibiotic resistance is an increasing problem whose geographic 
distribution is very different and which is presently considered as one 
of the major reasons for therapy failure. Cytotoxic H P  strains express- 
ing CagA are associated with peptic ulcer and gastric malignancies. 
It has been recently shown (Gastroenterology 1998;114: 214) that 
having CagA-negative HP strains may be a risk factor for therapy fail- 
ure; however, it is still unclear which relationship exists between 
antibiotic resistance and cytotoxic strains. 
Objectives: (1) To evaluate the prevalence of primary BP resis- 
tance to M T R  and CLA in our area. (2) To investigate whether cyto- 
toxic BE‘ strains expressing C3gA are associated with a different 
prevalence of antibiotic resistance. 
Materials and methods: A total of 448 consecutive dyspeptic 
patients (237M, 211E range 18-75 years, mean age 44 years) were 
included. None of the patients had been previously treated with 
M T R  and CLA. During endoscopy, a five biopsies were taken from 
antrum (three) and corpus (two) for histology, rapid urease test and 
culture. Culture was performed using blood-kee agar plates under 
micro-arrophilic conditions. The HP-positive cultures were then 
subcultured and antimicrobial susceptibility to M T R  and CLA was 
tested by a disk diffusion method. CagA status was determined by 
serology (RADIM). 
Results: BP was assessed in 146 out of 448 cultures (32.6%). 
Resistance to M T R  was detected in 61 cultures (41.8%) and resis- 
tance to CLA in 27 cultures (18.5%). In 88 patients with CagA-posi- 
tive status, 32 cultures were M T R  resistant (36.8%) and 18 CLA 
resistant (20%). 
Conclusions: A high prevalence of M T R  resistance (41 3%) and 
above all CLA resistance (18.5%) has been detected in our area. There 
was no significant difference in the prevalence of antimicrobial resis- 
tance between CagA-positive H P  strains (36.8% and 20% for M T R  
and CLA, respectively) and the general population of HP-positive 
patients (41.8% and 18.5%). 
(p6551 Comparison of dual and triple therapies for 
Helicobacter pylori infection 
L. Terra, R. Calzone, S .  Pellicanb, D. Mandica, E. Ciliberto, G. 
Monti. Department of Infectious Diseases, ‘S. Giouanni di Dio Hospital’, 
Crotnne, Italy 
Objectives: To evaluate double and triple therapies for Helicobacter 
pyfori infection in our series of patients (pts). 
Methods: Our study involved 253 pts (151 male, 102 female: 
mean age 44.2 years) who were shown to be infected by H.  pylori by 
three biopsies in antrum, three biopsies in corpus-fundus (histologic 
examination with Giemsa and hematoxylin-eosin stain) and with 
rapid urea test. 68 pts (group A) were treated for 14 days with 
omeprazole 40 mg (OMP) and amoxycillin 2 g (AMX) or ranitidine 
bismuth citrate 800 mg (RBC); 185 pts (group B) with OMP, AMX 
and tinidazole 1.5 g for 14 days or clarithromicin 1 g (CLA) for 1 
week, or with AMX, CLA and lansoprazole 60 mg or ranitidine 600 
mg for 1 week,all after dietetic preparation. 
Results: Eradication rates were 4247% (group A) and 75582% 
(group B). 12 pts (5%), 3 in group A and 9 in group B) interrupted 
treatment because of side effects (asthenia, diarrhea, abdominal pain). 
Conclusions: Our  study shows that 1-week triple therapy is well 
tolerated and that triple therapy with a proton pump inhibitor and 
two antibiotics is associated with significantly higher eradication rate 
than double therapy. 
A b s t r a c t s  2 6 1  
w] He/icobacter py/ori antigen in stools in a 
pediatric population 
L. Balbo', V. Perrucii2, G. Dotti2, A. Bellissimo', R. Marinoni', A. 
Musso' , 'Department of Pediatrics, Uniuersify of Turin, 'Department of 
Clinical Pathology, Rqirza Maxherita Children 's Hospital, Turin, M y  
Several techniques have been proposed for the diagnosis of H. pylori 
infection, both invasive (histology) and non-invasive (Urea Breath 
Test C I ~ .  or serologic mays). The evaluation of H. pylori status after 
therapy, i.e. eradication of the infection, is a problem not yet solved: 
serology is obviously useless, and invasive techniques are often refused 
by patients. An enzyme iinmunoassay able to detect H .  pylori antigen 
directly in stool specimens has recently been developed. We carried 
out a study in order to evaluate the sensitivity and the specificity of 
this test, and compared it with the urea breath test C1n (UBT). 
Our patients are all in the pediatric age range, and the advantages 
of a non-invasive method to detect infection and even more to eval- 
uate its eradication are great. 
We enrolled 60 patients in this study. In 34 cases, H. pylori infec- 
tion was diagnosed by histology, all confirmed also by UBT Cin. The 
detection of H. pylori in stools showed a sensitivity as high as 100% 
and a specificity as high as 97%. 
As early as 10 days after the end of therapy, the detection of H. 
pylori in stools seems to be highly sensitive and specific, easy to 
perform and cost-effective. 
lp6571 23s rRNA genotype in H. py/ori isolates 
resistant and susceptible to clarithromycin 
D. Domingo, T. Alarcon, N. Prieto, 1. Sinchez, J.C. Sanz, M. 
L6pez-Brea. Department of Microbiolon, Hospital Uniuersifario de La 
Princesa, Madrid, Spain 
Macrolides are first-line agents in the treatment of H .  pylori infection. 
Resistance to these antibiotics can cause failures in H. pyluri eradica- 
tion. The mechanism of resistance is due to a mutation in the 23s 
rRNA region. 
Objectives: To study, by PCR-RFLP, the mechanism of resis- 
tance in Spanish H. pylori clinical isolates and to demonstrate the lack 
of existence of this mechanism in susceptible strains. 
Methods: Sixty-five H. pylori strains (35 resistant and 30 suscep- 
tible to clarithromycin) were isolated from gastric biopsies obtained 
by endoscopy. Culture and identification were performed by standard 
methodology. Minimum inhibitory concentration (MIC) was deter- 
mined by an agar dilution method, using Mueller-Hinton agar plus 
7% horse blood which contained two-fold dilutions of clar- 
ithromycin (0.008-128 pg/mL). Plates were inoculated with a Steer 
replicator. DNA was extracted by the CTAB method. A 1.4-kbp 
fragment of the 23s rRNA sequence was amplified. The amplified 
products were subjected to restriction with Mboll and Bsal in order 
to detect the A-G mutation in 2142 and 2143 respectively Resistant 
strains negative for the A-G mutation were studied by mismatched 
PCR to detect the A-C mutation in 2142. 
Results: No mutation was found in the 30 susceptible strains 
tested. Of the 35 resistant strains, 11 (31%) showed the A-G muta- 
tion in 2142 and 19 (54%) showed the A-G mutation in 2143. In 5 
strains mutation A-C in 2142 was detected. A higher level of resis- 
tance was observed when the A-G mutation in 2143 was detected 
compared to the A-G mutation in 2142. 
Conclusions: Mutation in 2143 (A-G) was more prevalent in 
Spanish H .  pylori clinical isolates but higher MICs were observed 
when mutation in 2142 (A-G) was detected. No mutations were 
detected in susceptible strains. 
lp658) hpaA profiles of H. py/ori Spanish clinical 
isolates: relationship to the geographic origin 
and to the pathology observed 
0. Domingo, T. Alarcbn, N. Prieto, 1. Sinchez, M. Ltrpez-Urea 
Department ofhficrobiolon, Hospital Uniuersifario de La Prirlcrsa, 
Madrid, Spain 
Objectives: To compare hpaA profiles of H. pyluri isolates obtained 
from different Spanish sites: Ibiza (east), Madrid (center), Almeria 
(south) and Aviles (north), studying the association among the 
patterns and the presence of ulcer or gastritis. 
Materials and methods: One hundred and forty-three H .  pyluri 
clinical isolates were obtained from the culture of gastric biopsies 
obtained from adult patients. Culture and identification were 
performed by standard methodology. DNA was extracted using the 
CTAB method. A PCR was performed to amplify a fragment of 375 
bp corresponding to the h p d  gene. Amplified products obtained 
were subjected to restriction endonuclease digrction with Hit$ and 
SauIIIa. 
Results: The 143 hpaCPCR products, when mtrictcd with Hit$ 
and SauIlla, produced 3 and 4 patterns, named 1-3 and A-11 respec- 
tively. Patterns 1 and A were the most common in the four sites. 
Pattern 3 was not found in the strains obtained from the north, and 
the same applied to pattern D, which was not found in strains 
obtained from the west. In 104 patients a correlation between the 
pathology and h p d  profile was studied. It is descrihed in the table: 
Pathology I(%) Z(%) 3(%) A(%) B(%) C(%) D(%) 
Gastritis 25(32) lO(41) D(0) 23(31) 7(35) 3(75) 2(33) 
Ulcer 53(68) 14(58) 2(100) 51(69) 13(65) l(25) q67)  
~ ~ t n i  7s(100) 2qioo) 5(ioo) 7q1oo) 2ot1ta) ~(100) stloo) 
Conclusions: The distributions of KFLP types of gene hpuA in 
H. pylori obtained from different Spanish sites were not very differ- 
ent although there were two patterns that were not detected in two 
sites. Patterns 1, 2, 3, A, B and D were more common in strains 
obtained from patients with ulcers, and pattern C was most preva- 
lent in patients who suffered from gastritis. 
[p659] Serum anti-CagA antibodies in symptomatic 
gastric infection with Helicobacter pyiori 
A. Szkaradkiewicz, E. Andrzejewska, A. Jopek, H. Klincewicz, L. 
Hryniewiecki. Department of Medical Mirrobioloxy, Karul hfnrcirikowski 
University of Medical Sciences in Poznan, Pozmn,  Polarid 
Objectives: Evaluation of serum anti-CagA antibody preceiice in H. 
pyluri-infected patients with duodenal ulcer or with chronic superfi- 
cial gastritis. 
Methods: The studies were performed on 25 adult patients 
infected with H. pylori. Twenty-one of the patients werc diagnosed 
as having duodenal ulcer, while the remainder were found to cuffer 
from chronic superficial gastritis type B. The diagnosis of H .  pyluri  
infection was based on gastroscopy and sampling of two biopsies of 
the niucosa. Presence of H .  pylori in the biopsies was detected by 
microbiological testing (microbial culture in micro-aerophdic condi- 
tions). Serum anti-CagA antibodies of IgA and IgG clasw were 
detected using Helicobacter p120 (CAG A) ELlSA teyt (VIVA 
Diagnostica). 
Results: All patients with duodenal ulcer demonstrated the pres- 
ence of serum anti-CagA antibodies of the IgG class (mean optical 
density: 1 .I  220.62) and 11 of them showed the presence also of IgA 
class anti-CagA antibodies in the serum (mean optical density: 
0.90+0.52). Two of the 4 patients with chronic superficial gastritis 
type B showed the presence of both IgG and IgA clasc anti-CagA 
serum antibodies, one patient manifested the presence of only IgA 
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cut-off DA (%) SE (%) 
2 0.9 92.8 96.8 
2 1.1 95.7 96.8 
class anti-CagA antibodies, while the serum of the fourth patient 
contained no antibodies of ths  specificity. 
Conclusions: Anti-CagA seropositivity in the IgG class is strongly 
associated with duodenal ulcer in the course of H .  pylori infection 
and this suggests that CagA may play a significant role in ulcer patho- 
genesis. 
SP (%) 
50 
83.3 
Ip6601 Evaluation of whole-blood antibody test and 
enzyme-linked immunosorbent assay for 
serodiagnosis of Helicobacter pylori infection 
H. Malamou', S. Ladas', I. Varzakakos', G. Giota', l? Kitsanta3, S. 
Georgopoulos', C. Spiliadi3. S. Raptis2. 'Department of Clinical 
Mimobiology, Penteli Children's Hospital, 'Gastroenteroloxy Unit, 2nd 
Department oflnternai Medicine, Athens University, Athens, )Pathology 
Department, Evangelismos Hospital, Athens, Greece 
Objectives: To investigate the diagnostic value of a rapid whole- 
blood antibody test (RBT) and compare it with an enzyme-linked 
immunosorbent assay (ELlSA) for the detection of Helicobacter pylori 
(Hp) infection. 
Methods: In a prospective double-blind study, 59 patients (age 
range 25-78 years) referred to a tertiary center for endoscopy because 
of dyspepsia were studied. Patients were defined as Hp positive if 
histology and rapid urease test or Gram staining of crush biopsy 
smears were positive, and Hp negative if all tests were negative. An 
RBT detecting IgG antibodies to Hp (Flex Pack H.p., Abbott 
Diagnostics) was compared with an ELISA detecting IgG (quantita- 
tively) and 1gA (qualitatively) Hp serum antibodies (Milenia H.p. IgG, 
IgA, DPC). 
Results: Final assessment showed that 49/59 patients were Hp 
positive. The RBT had a sensitivity of 83% and specificity of 90%. 
The respective values for ELISA IgG serum antibohes were 96% and 
70%, and those for ELlSA 1gA antibodies were 92% and 70%. RBT 
true-negative patients had significantly different median IgG serum 
levels (34 U/mL) as compared to RTB true-positive (315 U/mL) and 
RTB false-negative patients (221 U/mL) @<0.001). 
Conclusions: The rapid whole-blood antibody test was less sensi- 
tive but more specific than the IgG or IgA serum antibodies. Its ease 
of use makes it a useful tool for primary care physicians aiming to 
diagnose and treat H .  pylori infection. 
Ip661) Evaluation of a new commercial EIA IPlatelia) 
for serodiagnosis of Helicobacter pylori in 
adults 
C. Tom, I .  Casado, P. Alvarez, J. Carb6, J. Samaniego, A. Iniguez, 
L. Montesano, I. Buhigas, M. Baquero. Department ofMicrobiology, 
Hospital Carlos 111, Madrid, Spain 
Objectives: To evaluate a new quantitative enzyme immunoassay 
(Platelia H. pylori: Sanofi Diagnostics Pasteur) for the diagnosis of 
Helicobacter pylori infection in adults. 
Methods: 70 serum samples corresponding to 70 endoscopied 
adults patients (37 males and 33 females; age range 21-80 years) were 
included in the study. Diagnosis of infection was established accord- 
ing to culture and histologic standard methods. Those in whom 
chronic superficial or atrophic gastritis was present but in whom 
Helicobacter pylori was not identified from biopsy were excluded from 
the study. Serum samples obtained at the time of the endoscopy were 
tested according to the manufacturer's recommendations. Two sero- 
logic cut-off points were employed (0.9 and 1.1). 
Results: The results in terms of diagnostic accuracy (DA), sensi- 
tivity (SE) and specificity (SP) of each serologic cut-off were: 
1- H. py/ori vacA and cagA genes in patients with 
peptic ulcers 
E. Trajkoversuska-Dokic', M. Pop-Aceva', N. Panoyski', M. 
Petroversuska', V. Serafimoversusk?. 'Institute of Microbiolo~,  
'Department .f Gastroenterology, Medical Faculty Skopje, R. Macedonia 
Objectives: To investigate the presence of the vacA genotype and its 
association with the cagA gene in H.  pylori isolates from patients with 
peptic ulcers. 
Methods: We have obtained biopsies from 23 patients who have 
undergone endoscopy and were diagnosed as having chronic gastri- 
tis. The DNA from H. pylori isolates was extracted directly from the 
biopsies using proteinase K. vacA signal sequences ( sla, slb, s2 ) and 
the middle region ( ml, m2 ) of the gene, as well as the cagA gene, 
were detected with PCR amplification using specific primers. 
Results: H.  pylon' infection was detected in 22 (95.6%) out of 23 
patients with peptic ulcer. Six H .  pylori isolates were sl/m2; 14 were 
s l /ml;  two were s2/m2; and none were s2/ml. All sl types of H .  
pylori isolates were cagA positive. 
Conclusions: The most frequent v a d  genotypes of H .  pylori 
isolated from the biopsies of patients with peptic ulcer were s l /ml  
and sl/m2. s2/m2 vacA genotype was present in two isolates only, 
whereas s2/mL was absent. 90.9% of the H .  pylori isolates with the 
s l  signal sequence were cagA positive. This finding indicates a strong 
association between the cagA gene and the sl  signal sequence of the 
v a d  gene in H .  pylori isolates from peptic ulcer patients. 
[-I Detection of H. pylori antigen in stool 
specimens by a new enzyme immunoassay 
method (HpSA) for diagnosis of H. pylori 
infection 
C. Kontou-Castellanou', N.E. Alexandropoulos', C. Liatsos2, B. 
Xiromeritou', S.S. Kastellanos', E. Thireos', A. Nakos2. 
DepartmentS of 'Microbiology and 'Gastroenterology, Hippokration 
Hospital, Athens, Greece 
Objectives: To evaluate the reliability of a new commercial EIA test 
(HpSA) for detection of HP infection in feces, compared to stan- 
dardued techniques such as Giemsa, clo-test, histologic evidence, and 
closer test for anti-HP antibodies. 
Patients and methods: Over 3 months (June to August, 1998), 
stool specimens from 48 consecutive endoscoped adult patients 
(female 14, male 34) with a history of dyspeptic symptoms were 
tested. The determination in the stool samples of H .  pylori antigen 
was performed by a commercial kit (HpSA, Meridian Diagnostic 
Inc.). Stool specimens were collected and submitted to the labora- 
tory to be stored at -70°C until the HpSA test was performed. HpSA 
is a sandwich EIA procedure. The cut-off for the test (HpSA) defined 
by optical density at 450/630 nm was 0.120. Also, we determined 
the presence of H. pylori antibodies in the sera of 48 patients by a 
closer test. 48 endoscopic biopsy samples from gastric antrum were 
examined for the presence of HP hy Gram-stained smear, Clo-test 
urease production and histopathologic evidence. 
A b s t r a c t s  
Clo-test Giemaa Histological Closer test HPSA assays were 61.5% and 100% sensitive and 100% and 71.4% specific 
35 34 32 (0.32-2900) i-espectively. The MarDx assay had the greatest number of cquivocal 
13 12 . .  13 13 11 (0.05-0.1) 
-H.P. +positive 34 35 
False (4 - 1 1 
False (+) 1 1 4 results (10 in total). Mikrogen and Milenia each had 4 and 5. After 
2 6 3  
successful therapy of patients with HP infection Conclusions: The Milenia ID Slot H .  pylori IgG assay was 
demonstrated to be a highly sensitive and specific scrodiagiiostic tool 
for the diagnosis of infections caused by H .  pyloui. As a side benefit 
of the immunoblot assay, the patient's imniunologic respomc to the 
virulence factor\ CagA and VacA can be determined 
lp6641 Two immunoassays for detecting H. p y h i  IgG 
B. Gerstenecker, G. Bode, W. Nilius, M. Ghadessi, S .  El Shami 
Research arid Develupnrwit, DPC Bierniann CmhH, Bad Nauheirn, 
Germany 
Objectives: The gold standard for diagnosing H .  pylori infections is 
histologic examination of gastric biopsy material and/or the ability 
to culture the organism from biopsy samples. To limit the need for 
itivasive procedures, serologic screening techniques have been devel- 
oped. The purpose of this study was to evaluate the performance of 
both the DPC IMMULITE and Milenia H. pylori IgG assays versus 
direct bacterial detection from gastric biopsy material for their 
utility as screening assays prior to performing endoscopic biopsy. 
Methods: A collection of 177 serum samples were tested with 
both the IMMULITE and Milenia H. pylori IgG assays. Biopsy niate- 
rials corresponding to each serum sample were evaluated by CLO, 
culture, and/or histologic examination. Discrepant results were 
resolved by Western blot (WB) analysis. Each serum sainple war also 
lp6661 IMMULITE H. pylorifor detection of serum IgG 
M. Ghadessi, J.-U. Lei, D. Sustarsic, T. Schutzbank, A.S. El Shami. 
Research and Development, Diqnosric Pmducts Corp., Lo.? AF?~L.~IT,  CA, 
USA 
Objectives: The detection of antibodies specific for H .  pylori  is gain- 
ing importance for the diagnosis of chronic gastritis associated with 
this organism. The purpose of this study was to evaluate the perfor- 
mance of the IMMULITE H .  pylori IgG assay for the detection of 
H .  pylori-specific antibodies. Methods: The IMMULITE H .  pyluri 
IgG assay utilizes a chemiluminescent EIA technique for thc detec- 
tion of antibodies to H .  pylori. Enclosed within the proprietary 
IMMULITE test unit is an H .  pylori antigen-coated polystyrene bead. 
Diluted patient sample is introduced into the test unit and incubated 
for 30 min. After a spin-wayh step, sample, excess reagent and 
wash solution are captured in a coaxial waste chamber. An alkaline 
tested with two additional commercially available kits, Virion H. pylori phosphatase-labeled monoclonal antibody, specific for human IgG, i s  
IgG (Serion liiiiiiunodingnostica GiiibH, Wurzburg, Germany), and introduced and another 30-iiiin incubation follows. The bead is then 
Pyloriset EIA-G (Orion Iliagnostica, Espoo, Finland). washed again and enzyme label is measured with a cheiiiiluiiiinrscent 
Results: The relative sensitivity/specificity values for the substrate, a phosphate ester of adniantyl dioxetane. A qualitative result 
IMMULlTE assay were 90.40/;,/87.8% and 93.2%/85.1% for the is obtained by comparing the patient result to an established cut-oty. 
Milenia kit compared with biopsy results. After resolution of the A collection of 177 serum samples were tested by both the 
discordant results by WEI analysis, the sensitivity/specificity of both IMMULITE and Sigma SIA Helicobacter pylori (HM-CAI') awy. 
assays increased to (18.1'%1/94.4% and 95.4%/98.4% respectively. In Results: The relative sensitivity and specificity value\ for the 
comparison, the Virion and Pyloriset assays were 91.1% and 93.7% IMMULITE assay versus Sigma were 96.7% and 07.6% respectively, 
sensitive, and 81.1% and 67.6% specific. with 97.2% agreement between the two awys. Conclusions: The 
Conclusions: The excellent performance characteristics of both excellent performance characteristics of the IMMULITE H .  pylori 
the IMMULITEBand Milenia H .  pylori IgG assays make thein suit- IgG assay make it suitable for screening patients for qualitative dctec- 
able for screening patients prior to performing endoscopic procedures. tion of IgG antibody to Helicobacter pylori . 
lp665( Evaluation of the Milenia ID BLOT H. pylori )p6671 Growth of Helicobacter pylori in a blood-free 
assay agar medium: relation to clarithromycin 
resistance 
U. Gerstenecker, K. Jaggi, E. Unver, S .  El Shami. Researrh and 
Deidopmrict, DPC Biermann GmbH, Bad Nanheim, Germany 
Objectives: To compare the performance of the Milenia ID 
imniunoblot Helicobarter pylori system versus direct specimen detec- 
tion, ac well as two commercially available ininiunoblotting assays, for 
the diagnosis of infections due to H .  pylori. 
Methods: The Milenia ID Blot H. pylori IgG was evaluated 
againct the Iminunoblot H .  pylori IgG (Mikrogen GmbH, Munich, 
Germany) and H. pylori IgG MarSlot (Marl>x, Carlsbad, CA, USA). 
The results of all three were compared to the results of direct 
pathogen detection (Urea Breath Test, CLO test, histology and 
culture). Discordant results between the imniunoblot and biopsy 
T. Alarcon, 11. Doniingo, N. Prieto, M. Lopez-Brea. Mirrobinlo,q)~, 
Hospital de la Princesa, Madrid, Spain 
Objectives: Helicohacrerpylori (Hp) is a fastidious microorganism that 
requires blood or derivatives to grow in culture medium. Although 
blood inediuni supports very well the growth of Hp in  several sitii- 
ations, blood-free medium is recommended. The aim of thic study 
was to determine the ability of1Y Hp strains to grow in braiii-licart 
infusion agar supplemented with yeast extract and fetal calf serum .ind 
to relate it to the resistance or susceptibility to clarithroniycin (CLA). 
Materials and methods: 49 Hp strains were cultured from 
gastric biopsies taken at routine endoscopy. Biopsy specimens wcre 
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processed and microorganisms identified following standard microbi- 
ological procedures. The brain-heart infusion agar (BHIA) was 
prepared according to the manufacturer's recommendations (Oxoid) 
and supplemented with 10% fetal calfserum (FCS). At the same time, 
plates with Mueller-Hinton agar (MHA) supplemented with 7% 
horse blood (HB) were prepared. A high inoculum was applied by 
using a Steer replicator in both plates and incubated in a COz incu- 
bator for 3 days. Resistance to CLA was determined using an agar 
dilution method, and resistance was defined as MIC 4 mg/L. 
Results: All strains were able to grow in MHA with HB in the 
same conditions. Nine strains were CLA resistant and 40 were CLA 
susceptible. The numbers of strains susceptible or resistant to CLA 
that were able to grow in BHIA were as follows: growth in 
BHI+FCS was positive for 2 out of the 9 (22.2%) CLA-resistant and 
for 28 out of the 40 (70%) CLA-susceptible strains. 30 out of the 49 
clinical isolates growth 
Conclusions: No growth on BHIA+FCS was observed with a 
high percentage of the strains tested (38.8%). The growth was worse 
when considering the clarithromycin-resistant strains. 
(p6681 Clarithromycin against metronidazole-resistant 
H. pylori 
M. Lopez-Brea, D. Domingo, I. Sanchez, N. Prieto, T. Alarcon. 
Clinical Micro&iology, Hospital de la Priwcesa, Madrid, Spain 
Clarithromycin, amoxycillin, tetracycline and metronidazole are the 
most frequent antimicrobial agents used for Helicobacter pylori infec- 
tion. However, resistance to metronidazole and more recently to clar- 
ithromycin constitute one major determinant in the failure of 
eradication treatments. 
Objectives: To determine the activity of clarithromycin against 
metronidazole-resistant Helicobacter pylori Spanish clinical isolates and 
determine the rate of resistance to both antibiotics. 
Materials and methods: 160 strains of H .  pylori resistant to 
metronidazole (MIC 8 mg/L) were obtained from gastric biopsies 
taken at routine endoscopy, cultured and identified by standard 
methodology. Three groups of resistant strains were considered: 31 
nietronidazole-resistant strains isolated from children, 77 from adults 
from different hospitals and 52 from Hospital de la Princesa. Patients 
in the last group are usually treated for H .  pylori infection and when 
a treatment failure exists, biopsy samples are sent for culture. Strains 
were grown in BHI plus 10% fetal calf serum for 2 days. Minimum 
inhibitory concentrations (MICs) were determined by an agar dilu- 
tion technique using Mueller-Hinton agar plus 7% lysed horse blood. 
The inoculum was applied with a Steer replicator and plates were 
incubated in a 5% CO2 atmosphere at 37'C for 3-5 days. 
Clarithromycin resistance was defined as MIC 4 mg/L. 
Results: The percentage of resistance to clarithromycin in the 
metronidazole-resistant strains was as follows: 14.3% (23 out of 160 
strains). According to the different groups, the clarithromycin resis- 
tance was: 4 out of31 from group I (12.9%), 4 out of77 from group 
I1 (5.1%) and 15 out of 52 from group 111 (28.8%). 
Conclusions: A high percentage of susceptibility to clarithro- 
niycin in nietronidazole-resistant H. pylori strains was found. 
11>669] In vitro activity of ascorbic acid against H. 
py/ori clinical isolates 
M. Lopez-Brea, D. Doniingo, T. Alarcon. Cfinicai Microbiology, 
Hospital de la Princesa, Madrid, Spain 
Treatment with single antimicrobial agents has failed to eradicate H. 
pylori (Hp) from the gastric mucosa. The most successful treatment 
for the eradication of the microorganism includes combination of 
colloidal bismuth subcitrate or proton pump inhibitors with antibi- 
otics such as tetracycline, amoxycillin, metronidazole and clar- 
ithromycin. However, a consensus agreement for the optimal therapy 
(greatest efficacy with fewest secondary effects and lowest cost) has 
to be established and new agents to be used in Hp treatment are 
required. The role of vitamin C, both in vitro and in vivo, in Hp 
infection has been studied. 
Objectives: To determine the in vitro activity of vitamin C 
against a maximum of 25 Hp clinical isolates. 
Materials and methods: 24 Hp clinical isolates cultured from 
gastric biopsies taken at routine endoscopy were studied. Ascorbic 
acid was diluted and 2-fold dilution prepared to obtain a final 
concentration range of 4000 to 64 mg/L. An agar dilution method 
using brain-heart infusion agar supplemented with yeast extract and 
fetal calf serum was used. A high inoculnm (approximately 10" 
CFU/mL) was applied using a Steer replicator and plates were incu- 
bated in a COz incubator for 2-5 days. Minimum inhibitory concen- 
tration (MIC) was recorded as the lowest concentration that inhibited 
visible growth. 
Results: The number and the percentage of strains that were 
inhibited at each concentration of ascorbic acid were as follows: 4 
strains with MIC=125 mg/L, 6 with MIC=250 mg/L, 8 with 
MIC=500 mg/L, 6 with MIC=1000 mg/L and 1 with MIC=2000 
mg/L. 
Conclusions: Ascorbic acid shows good in vitro activity against 
H. pylori clinical isolates and could explain some of the beneficial 
properties of vitamin C. 
IP670) Comparison of two non-invasive tests for the 
control of efficacy of eradication of 
Helicobacter pylori (Hp) after treatment 
A. Gonzalez-Escalada, M. Garau, S. Perea, C.P. Alvarez, A. 
Gonzalez-Ruiz, M.J. Ramos, E. Salto, A. Fuertes, A.R. Noriega. 
Microbiology, Hospital 12 de Octubre, Madrid, Spain 
Objectives: To compare two non-invasive tests, Urea C13 breath- 
test (BT) and ELISA Hp antigen detection, in patients subjected to 
eradication treatment of Hp. 
Methods: The results of BTand ELISA Hp antigen in stool spec- 
imens were compared in 132 patients 8-10 weeks after the comple- 
tion of an eradication treatment. Each test was performed in different 
laboratories and the results were compared thereafter. 
Results: In 11 1/132 (85%) patients the results were in agreement 
(89 negative; 22 positive). In 21 patients, however, results were 
discordant: BT+ and ELISA-=7; BT- and ELISA+=14. In the 7 
BT+/ELISA; the counts of BT were low, so they should be consid- 
ered positive borderline. Of the 14 BT-/ELISA+, 4 (3%) have high 
ELISA values, so the results of both tests were in clear disagreement. 
Conclusions: The ELlSA Hp antigen detection in stool speci- 
mens is a reliable, inexpensive and simple procedure that can be 
performed in most laboratories and gives results comparable to those 
of the most complex and widely used BT. 
Ip673J New approach in the therapy of recurrent 
Helicobacter pylori infections 
J. Hromec, I. Piv, S. Krcniery IVth Medical Department, Cornenins 
University, Hospitaf Petrzalka, Bratislava, Slovak Repirbfic 
Recurrent Helicobacter pylori (Hp) infections often impose a major 
therapeutic problem in clinical practice. A total of 405 patients with 
recurrent symptomatic Hp gastritis (histologically proven) were 
A b s t r a c t s  265 
treated for 7 days with a conibination of ranitidine, bismuth, inetron- 
idazolc and doxycycline. In 44 of these patients (10.86%), Hp infec- 
tion was not eradicated at follow-up 6 weeks after treatment. In these 
patients a 14-day combination therapy with omeprazole (40 ing/day), 
roxithromycin (200 mg b.i.d.) and bismuth (240 nig b id . )  was used. 
Therapeutic success using this triple combination was achieved in 43 
of 44 patients (97.7) who were Hp negative at 6 weeks and 6 months 
after the end of this therapy. 
Conclusions: The proposed therapeutic approach with high effi- 
cacy and good tolerance can be recommended for further clinical 
evaluation and the therapy of recurrent symptomatic Hp infections. 
[p674( Diagnosis of Helicobacter pylori-associated 
chronic duodenitis 
M. Konareu, A. Lityjakov, U. Krylov, M. Matveenko. Department .f 
Mrdirinr, State Mrdicnl Institute, Vitcbsk, Belarus 
Objectives: To investigate chronic duodenitis with persistence of 
Hrliculiactrr pylori (HP) on gastric metaplasia of duodenal bulbus. 
Methods: Fifty-seven patients with chronic duodenitis have been 
examined. The diabmosis was made on the base of tissue biopsy data. 
H .  pylori status was confirmed by the inorphologic, immunologic 
method ( H .  pylori IgG ELISA, Diagnostic Automation, Inc., USA) 
and urease test (Jatrox-H.p. Test, Germany). The density of bacteria 
was determined according to the four-step scale. Regions of gastric 
nletaplasia of duodenum were confirmed by alcian blue (Serva) stain- 
ing. 
Results: HI' was present in the stomachs of 25 (43.9%) patients, 
on the gastric metaplasia of duodenal bulbus in 12 (21.1%) patients. 
Seven (12.3%) patients had BP only in duodenal bulbus, without 
persistence of microorganisms in gastric mucosa. There was a previ- 
ous history of peptic ulcer dicease in 42.9% of patients and erosive 
process in 28.6'%1. Endoscopically, in addition to acute chronic super- 
ficial duodenitis with gastric iiietaplasia of duodenal bulbus, peptic 
ulcer was found in 57.1%) ofpatients and multiple erosive process in 
28.6%. Histology of duodenal tissue revealed chronic ~nflanimation, 
activity, superficial duodenitis and gastric nietaplasia of bulbus in 
1000'Hr of patients, and erosive process in 28.6% All of the patients 
with chronic duodenitis had a high pH of gastric juice on an empty 
stomach (1.25-1.95). Hictology of gastric tissue revealed chronic 
inflamination (91.4%), activity (76.7%), superficial gastritis (60.OK), 
gland atrophy of the stomach (40.0%), intestinal nietaplasia (26.7%) 
and erosive process (16.7%). 
Conclusions: Indications for duodenal tissue biopsy for determi- 
nation of Helicubacterpylori are: (1) ulcer dyspepsia and duodenal ulcer 
in anamnesis; (2) acute duodenitis with gastric metaplasia, and niulti- 
ple erosive and ulcer processes by endoscopy. 
lp675] The determination of IgG anti-Helicobaeter 
pylori antibodies in pregnant women and 
Venezuelan children 
M. Correnti', M.E. Cavazza', K.O. Pitiero3 , M.I. Urrestarazu', Z. 
Carvajal', R.A. Piiiero'. 'Laboratorio dr Certitica Molrrular, Itistitutu 
dc Omolqia y Hrniatolqgia, MSAS-LJCV 21ns~ituto de Biomedicinn, 
MSAS-UC C: 'Centre Obstltrico, 'Scrvicio de Gasrr[)enter[)/o'~ia, Hospital 
Vargos, Caratas, Kwrzuela 
Objectives: Evaluation of the seroprevalence of IgG anti-H. yylori 
antibodies in asymptomatic pregnant women and serum samples from 
umbilical cord blood at the monient of the baby's birth, compared to 
the seropresalence in the juvenile populatiori. 
Methods: Serum samples from 160 hralthy children (age: 1-10 
years) from different states of Venezuela, 50 serum samples from preg- 
nant women without gastroduodenal infection and 50 serum sainples 
from umbilical cord blood were studied by ELISA test for the deter- 
mination of IgG anti-H. pylori antibodies. 
Results: The prevalence of IgG anti-H. pylori antibodies was high 
in the pediatric population (62.5%); only 37.5% of the children in 
the group were seronegative (p<O.OOOl). The seropresalence 
observed in the serum samples from pregnant women and umbilical 
cord samples was 54% in both groups. 46% of the mothers arid of the 
matched-up samples of umbilical cord blood were negative for IgG 
anti-H. pylori antibodies. 
Conclusions: These results suggest that anti-H. pylori specific 
antibodies pass the placental barrier and have a protective role during 
the first months of life. The prevalence of IgG anti-H. pylori anti- 
bodies in samples from asymptomatic women probably indicates an 
infected group. The serologic test indicates a high IgC; anti-H. pylori 
immunoresponse in the pediatric population. Thic study was 
supported by grant S1-96001408-CONICIT. 
Enteric pathogens 
lP6761 BBL CHROMagar 0157, a new chromogenic 
medium for the isolation of E. coli 0157 
K. Hamtnann, 1'. Chapman. Research awd Development, Brrturi 
Dirkinson GmbH, Heidclbey, Germarty 
Objectives: To create a chromogenic niedium for the detection of 
E. coli 0157,  based on LLglucnronidase negativity, which is suitable 
for human clinical, animal and food samples, perforniing a t  least *IS 
well as selective Sorbitol-MacConkey Agar (CT-SMAC). 
Methods: CHROMagar 01 57 dehydrated medium was supple- 
mented with selective agents to inhibit most of the undesired species 
such as Protrotcus, Psrtcdornorias, and Aerorwonar. The manufacturing 
procedures were modified to allow the industrial preparation as a 
plated medium with a shelf-life of a t  least 8 weeks. The resulting 
medium (BCA) was tested with both 0 1 5 7  and undesired strains. A 
larger field investigation with 1104 samples from bovine and ovine 
carcasses and human fecal specimens was conducted a t  Shefield PHL. 
For comparison, CT-SMAC from both UDMS (BCT) and Shefield 
PHL (SCT) were used. Specimens were plated onto the media after 
immunomagnetic separation (DYNAL, Oslo, Norway). 
Results: All of the 0 1 5 7  reference and clinical strains produced 
excellent growth of rose-violet ('mauve') colonies on UCA. The 
recovery rate of low CFUs was higher than on the non-selective 
reference medium. Among the 40 non-0157 strains tested, only one 
strain of Enterobacrrr sekarakii produced weak growth of ~iiauve- 
colored colonies. Most of the other strains were fully inhibited, and 
only a few produced blue or colorless colonies. In the field investi- 
gation, the positivity rates of the three media were nearly identical. 
The number of false positives was higher on SCT than on I3CT and 
BCA. 
Conclusions: BBL CHKOMdgar 0157 is an excellent altrrna- 
tive to Sorbitol-MacConkev-based media. 
